SCHEMBL8556232

SCHEMBL8556232

CC(c1cccc2c1C(=O)NC2=O)C1CNCCO1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPK10 P53779 1/20 0.37
SLC6A2 P23975 15/20 0.36
SLC6A4 P31645 14/20 0.36
SLC6A3 Q01959 8/20 0.36
MLNR O43193 1/20 0.36
ADRB2 P07550 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2C P28335 1/20 0.36
OPRK1 P41145 1/20 0.36
KCNH2 Q12809 1/20 0.36
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8555645 0.89 SLC6A2 (0.33) SSTR4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL28107993 0.87 PARP1 (0.40) SSTR4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL28107995 0.82 MEN1 (0.40) SSTR4KDM4EALDH1A1SLC6A2SLC6A4
SCHEMBL8559709 0.80 SLC6A2 (0.36) SSTR4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7408917 0.72 SLC6A2 (0.43) SSTR4KDM4EALDH1A1SLC6A2SLC6A4
SCHEMBL166123 0.70 HPGD (0.47) KDM4EALDH1A1HPGDHSD17B10SLC6A2
SCHEMBL27625802 0.69 DRD2 (0.39)
SCHEMBL28236498 0.69 SLC6A2 (0.41) SSTR4KDM4EALDH1A1SLC6A2SLC6A4
SCHEMBL8556098 0.69 SLC6A2 (0.37) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL1961849 0.68 SLC6A2 (0.57) KDM4EALDH1A1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575954-B1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI SRL (IT) 1998-09-02 EP disclosed
US-5424451-A Used as cholinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1995-06-13 US disclosed
US-5302593-A Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1994-04-12 US disclosed
EP-0575954-A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1993-12-29 EP disclosed